Related Experiment Videos

β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells

Jing Liu1, Xue-Jun Hu, Bo Jin

  • 1Department of Medical Oncology, The First Hospital, China Medical University, Shenyang, China.

Abstract

Insights

β-Elemene, a traditional Chinese medicine, effectively inhibits non-small-cell lung cancer (NSCLC) A549 cell viability by inducing apoptosis and autophagy. Combining β-elemene with autophagy inhibitors may offer a novel therapeutic strategy for advanced NSCLC.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • β-Elemene is a traditional Chinese medicine with demonstrated anticancer properties.
  • Non-small-cell lung cancer (NSCLC) remains a significant global health challenge requiring novel therapeutic approaches.

Purpose of the Study:

  • To investigate the antitumour effects of β-elemene on human NSCLC A549 cells.
  • To elucidate the underlying mechanisms, including apoptosis and autophagy induction, and the involvement of the PI3K/Akt/mTOR/p70S6K1 signaling pathway.

Main Methods:

  • Cell viability assessed using MTT assay.
  • Apoptosis measured by flow cytometry.
  • Protein expression analyzed via Western blotting.
  • Autophagy evaluated using fluorescence and transmission electron microscopy.

Main Results:

  • β-Elemene dose-dependently inhibited A549 cell viability, inducing apoptosis.
  • The compound suppressed the PI3K/Akt/mTOR/p70S6K1 signaling pathway.
  • β-Elemene triggered significant autophagy, evidenced by LC3-II and Atg5-Atg12 accumulation.
  • Autophagy inhibition with chloroquine enhanced β-elemene's antitumour efficacy.

Conclusions:

  • β-Elemene induces apoptosis and protective autophagy in NSCLC A549 cells by inhibiting the PI3K/Akt/mTOR/p70S6K1 pathway.
  • Combination therapy of β-elemene with autophagy inhibitors presents a promising strategy for treating advanced NSCLC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...